For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 778 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Schoggins JW, Falck-Pedersen E.  2009.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.. Virology. 395(1):10-20.
Schoolnik GK, Voskuil MI, Schnappinger D, Yildiz FH, Meibom K, Dolganov NA, Wilson MA, Chong KH.  2001.  Whole genome DNA microarray expression analysis of biofilm development by Vibrio cholerae O1 E1 Tor.. Methods Enzymol. 336:3-18.
Schrader SM, Vaubourgeix J, Nathan C.  2020.  Biology of antimicrobial resistance and approaches to combat it.. Sci Transl Med. 12(549)
Schubert P, Schnappinger D, Pfleiderer K, Hillen W.  2001.  Identification of a stability determinant on the edge of the Tet repressor four-helix bundle dimerization motif.. Biochemistry. 40(11):3257-63.
Schwer B, Sanchez AM, Shuman S.  2020.  Inactivation of fission yeast Erh1 de-represses pho1 expression: evidence that Erh1 is a negative regulator of prt lncRNA termination.. RNA. 26(10):1334-1344.
Schwer B, Lehman K, Saha N, Shuman S.  2001.  Characterization of the mRNA capping apparatus of Candida albicans.. J Biol Chem. 276(3):1857-64.
Schwer B, Meszaros T.  2000.  RNA helicase dynamics in pre-mRNA splicing.. EMBO J. 19(23):6582-91.
Schwer B, Sawaya R, C Ho K, Shuman S.  2004.  Portability and fidelity of RNA-repair systems.. Proc Natl Acad Sci U S A. 101(9):2788-93.
Schwer B.  2001.  A new twist on RNA helicases: DExH/D box proteins as RNPases.. Nat Struct Biol. 8(2):113-6.
Seamons A, Sutton J, Bai D, Baird E, Bonn N, Kafsack BFC, Shabanowitz J, Hunt DF, Beeson C, Goverman J.  2003.  Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity.. J Exp Med. 197(10):1391-7.
Seehus CR, Aliahmad P, de la Torre B, Iliev ID, Spurka L, Funari VA, Kaye J.  2015.  The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor.. Nat Immunol. 16(6):599-608.
Seimon TA, Kim M-J, Blumenthal A, Koo J, Ehrt S, Wainwright H, Bekker L-G, Kaplan G, Nathan C, Tabas I et al..  2010.  Induction of ER stress in macrophages of tuberculosis granulomas.. PLoS One. 5(9):e12772.
Shan J, Chouchane A, Mokrab Y, Saad M, Boujassoum S, Sayaman RW, Ziv E, Bouaouina N, Remadi Y, Gabbouj S et al..  2019.  Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.. Front Oncol. 9:1328.
Shan D, Chen L, Njardarson JT, Gaul C, Ma X, Danishefsky SJ, Huang X-Y.  2005.  Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.. Proc Natl Acad Sci U S A. 102(10):3772-6.
Shastry S, Steinberg-Neifach O, Lue N, Stone MD.  2018.  Direct observation of nucleic acid binding dynamics by the telomerase essential N-terminal domain.. Nucleic Acids Res. 46(6):3088-3102.
Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK.  2001.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.. Proc Natl Acad Sci U S A. 98(13):7534-9.
Shi C, Tiwari D, Wilson DJ, Seiler CL, Schnappinger D, Aldrich CC.  2013.  Bisubstrate Inhibitors of Biotin Protein Ligase in Mycobacterium tuberculosis Resistant to Cyclonucleoside Formation.. ACS Med Chem Lett. 4(12)
Shi X, Liu J, Xiang Z, Mitsuhashi M, Wu RS, Ma X.  2004.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.. Int J Cancer. 110(4):570-8.
Shi S, Blumenthal A, Hickey CM, Gandotra S, Levy D, Ehrt S.  2005.  Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.. J Immunol. 175(5):3318-28.
Shi S, Ehrt S.  2006.  Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis.. Infect Immun. 74(1):56-63.
Shi X, Cao S, Mitsuhashi M, Xiang Z, Ma X.  2004.  Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms.. J Immunol. 172(7):4111-22.
Shi S, Nathan C, Schnappinger D, Drenkow J, Fuortes M, Block E, Ding A, Gingeras TR, Schoolnik G, Akira S et al..  2003.  MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis.. J Exp Med. 198(7):987-97.
Shi C, Geders TW, Park SWoong, Wilson DJ, Boshoff HI, Abayomi O, Barry CE, Schnappinger D, Finzel BC, Aldrich CC.  2011.  Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosis.. J Am Chem Soc. 133(45):18194-201.
Shimono N, Morici L, Casali N, Cantrell S, Sidders B, Ehrt S, Riley LW.  2003.  Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.. Proc Natl Acad Sci U S A. 100(26):15918-23.
Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.  2005.  Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.. Biochem Biophys Res Commun. 326(4):782-7.